Dunhill Financial’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.56K Hold
3,180
﹤0.01% 589
2025
Q1
$2.51K Hold
3,180
﹤0.01% 696
2024
Q4
$5.25K Hold
3,180
﹤0.01% 529
2024
Q3
$11.1K Hold
3,180
0.01% 357
2024
Q2
$10.4K Hold
3,180
0.01% 280
2024
Q1
$23.3K Hold
3,180
0.02% 162
2023
Q4
$11.9K Buy
+3,180
New +$11.9K 0.01% 185